Larimar Therapeutics, Inc. · NASDAQ:LRMR
Clayton Russell bought 3,322 Larimar Therapeutics, Inc. shares (Form 4)
Traded Nov 16, 2026 · Filed Nov 18, 2026
On Nov 16, 2026, Clayton Russell (Chief Medical Officer) bought 3,322 Larimar Therapeutics, Inc. shares at US$3.01 for US$9,999, leaving 74,765 shares. Filed Nov 18, 2026 (Form 4).
- Bought
- 3,322 shares
- Price
- US$3.01
- Value
- US$9,999
- Holding after
- 74,765 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Stock | Buy | 3,322 | US$3.01 | 74,765 | Direct |
Source
Download original · View original at SEC